NO921495L - Oligosakkarid og fremgangsmaate for dets fremstilling - Google Patents

Oligosakkarid og fremgangsmaate for dets fremstilling

Info

Publication number
NO921495L
NO921495L NO92921495A NO921495A NO921495L NO 921495 L NO921495 L NO 921495L NO 92921495 A NO92921495 A NO 92921495A NO 921495 A NO921495 A NO 921495A NO 921495 L NO921495 L NO 921495L
Authority
NO
Norway
Prior art keywords
oligosaccarid
procedure
preparation
oligosaccharide
sulfate
Prior art date
Application number
NO92921495A
Other languages
English (en)
Norwegian (no)
Other versions
NO921495D0 (no
Inventor
Hiroko Habuchi
Sakaru Suzuki
Koji Kimata
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of NO921495D0 publication Critical patent/NO921495D0/no
Publication of NO921495L publication Critical patent/NO921495L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO92921495A 1991-04-16 1992-04-15 Oligosakkarid og fremgangsmaate for dets fremstilling NO921495L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11090591 1991-04-16

Publications (2)

Publication Number Publication Date
NO921495D0 NO921495D0 (no) 1992-04-15
NO921495L true NO921495L (no) 1992-10-19

Family

ID=14547637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921495A NO921495L (no) 1991-04-16 1992-04-15 Oligosakkarid og fremgangsmaate for dets fremstilling

Country Status (11)

Country Link
US (1) US5849722A (fi)
EP (1) EP0509517B1 (fi)
KR (1) KR920019810A (fi)
AT (1) ATE148470T1 (fi)
AU (1) AU656953B2 (fi)
CA (1) CA2066305A1 (fi)
DE (1) DE69217104T2 (fi)
FI (1) FI921689A (fi)
MX (1) MX9201801A (fi)
NO (1) NO921495L (fi)
ZA (1) ZA922830B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
WO1994020512A2 (en) * 1993-03-01 1994-09-15 Glycan Pharmaceuticals, Inc. Analogs for specific oligosaccharide-protein interactions and uses therefor
GB9306255D0 (en) * 1993-03-25 1993-05-19 Cancer Res Campaign Tech Heparan sulphate oligosaccharides having hepatocyte growth factor binding affinity
US6140481A (en) * 1994-07-01 2000-10-31 Seikagaku Corporation Process for producing desulfated polysaccharide, and desulfated heparin
GB9722604D0 (en) * 1997-10-28 1997-12-24 Cancer Res Campaign Tech Heparin-binding growth factor derivatives
JP4262979B2 (ja) * 2000-11-21 2009-05-13 ザ・テキサス・エイ・アンド・エム・ユニバーシテイ・システム Ｆｇｆアフィニティークロマトグラフィー
WO2002076475A2 (en) * 2001-03-23 2002-10-03 Bioparken As Glycosaminoglycan anticoagulants derived from fish
CH696701A5 (de) * 2001-12-18 2007-10-15 Hoffmann La Roche Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen.
US20060183712A1 (en) * 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
JP6070693B2 (ja) * 2012-03-30 2017-02-01 味の素株式会社 硫酸化化合物を含む幹細胞増殖用培地
JP6321786B2 (ja) 2013-05-16 2018-05-09 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ ヘパラン硫酸
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
SG11201704085QA (en) 2014-11-19 2017-06-29 Agency Science Tech & Res Heparan sulphates for use in repair and/or regeneration of skin
CN104530262B (zh) * 2015-01-26 2016-08-24 安徽科宝生物工程有限公司 一种从猪肺中提取肝素的生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
FR2597484B1 (fr) * 1986-04-17 1988-12-23 Sanofi Sa Glycosaminoglycanes de type heparine ou heparane-sulfate dotes d'une activite sur la division et la differentiation cellulaires, leur preparation et leurs applications therapeutiques.
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
JPH0240399A (ja) * 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
PT93847A (pt) * 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same

Also Published As

Publication number Publication date
EP0509517A3 (en) 1993-09-01
MX9201801A (es) 1992-10-30
ZA922830B (en) 1993-01-27
US5849722A (en) 1998-12-15
NO921495D0 (no) 1992-04-15
ATE148470T1 (de) 1997-02-15
DE69217104D1 (de) 1997-03-13
EP0509517B1 (en) 1997-01-29
AU1500392A (en) 1993-03-11
FI921689A0 (fi) 1992-04-15
KR920019810A (ko) 1992-11-20
EP0509517A2 (en) 1992-10-21
DE69217104T2 (de) 1997-06-05
FI921689A (fi) 1992-10-17
CA2066305A1 (en) 1992-10-17
AU656953B2 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
NO921495D0 (no) Oligosakkarid og fremgangsmaate for dets fremstilling
KR970003057B1 (en) Lyophilized pharmaceutical composition of neocarzinostatin derivative
IL90411A (en) Heparin derivatives and process for their preparation
GB2249315B (en) A process for producing an aqueous solution of sodium hyaluronate
IL84177A (en) Process for the manufacture of alginates and other uronic acid compounds with altered physical properties
GB8806737D0 (en) Therapeutic composition & method
HUT53871A (en) Process for producing 1,4-disubstituted piperidinyldiketone derivatives
HUT62315A (en) Process for producing agent promoting hepatocyte growth
HU907113D0 (en) Process for producing analogues of 2', 3'-didesoxy-2'-fluoro-arabino-nucleoside
HUT51300A (en) Process for producing substituted alkylamide derivatives of teicoplanin compounds
HUT57724A (en) Process for producing dialkyl-(2,3-pyridinedicarboxylate) and its derivatives
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
CA2073292A1 (en) Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof
DE69027157D1 (de) Verfahren zur Herstellung eines Süssstoffes auf Grund des Aspartams, die in einer trockenen knollenähnlichen Form ist
DE3569075D1 (en) Method and compositions for use in the treatment of fireblight
CS472690A3 (en) Combination preparation with antithrombotic effect
IL89242A (en) Process for producing a recombinant microorganism capable of converting glucose into 2-keto-l-gulonic acid,the microorganism obtained by said process and its use in converting glucose into 2-keto-l-gulonic acid
HU9200900D0 (en) Process for the production of cyclic peroxi-acethale-lacton, -lactol and ether derivatives
GR3008746T3 (fi)
HUT60509A (en) Process for producing monomer and 125 i-marked derivatives of t-butyloxycarbonyl-l-tyrosylpeptidoglycan
AU624690B2 (en) A mutant of microbacterium, a strain 851r, and a process for producing 851 nutrient solution by application of the strain
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
ZA882762B (en) Novel derivative of d.25,process for its preparation,its use as an immunostimulant,and pharmaceutical compositions containing the derivative
KR900001723A (ko) 저분자량의 소디윰알긴네이트의 제조방법 및 고흡수성 지혈대
ITPD920205A1 (it) Acilazione selettiva del gruppo 6-idrossile dei residui n-acetilglucosamina dei derivati dell'acido ialuronico